Aurobindo Pharma Unit-7 gets 7 USFDA observations Medical Dialogues Bureau8 Oct 2019 2:54 PM ISTThe United States Food and Drug Administration (USFDA) conducted a Current Good Manufacturing Practices (CGMP) inspection at the company's unit-7...
Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over Medical Dialogues Bureau23 Sept 2019 10:00 AM ISTRanitidine is an Over-The-Counter (OTC) and prescription drug which decreases the amount of acid created by the stomach.Hyderabad: Dr Reddy's...
CDSCO releases updated list of 2006 WHO GMP certified drug manufacturers; Details Farhat Nasim6 Jun 2019 12:11 PM ISTNew Delhi: The apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has recently released an updated list of WHO GMP...
Sun pharma, Dr Reddys, others deny allegations of price fixing in US Garima16 May 2019 9:35 AM ISTIn separate clarifications to stock exchanges, the companies including Glenmark, Sun Pharma, Dr Reddy's, Aurobindo Pharma denied the accusations and...
Inflated prices to 1000 per cent; Lupin, Sun Pharma, Dr Reddys, others face lawsuit Farhat Nasim14 May 2019 4:57 PM ISTMumbai: In a major setback, a group of domestic pharmaceutical companies including Zydus Cadila, Lupin, Aurobindo Pharma, Dr Reddy's Labs, Wockhardt,...
Lupin, Aurobindo Pharma recalls multiple lots of BP drug including VALSARTAN Farhat Nasim1 April 2019 9:50 AM ISTAurobindo Pharma is also recalling certain lots of Amlodipine and Valsartan Tablets USP 10mg/160mg in 30 count bottles for CGMP deviations.New Delhi:...
Aurobindo looks for inorganic growth prospects in East Europe Ruby Khatun Khatun27 Nov 2017 10:40 AM ISTMumbai: Hyderabad-based Aurobindo Pharma is looking at inorganic growth opportunities in Eastern Europe and other geographies for deeper market...
Aurobindo Pharma Q2 net up 29 percent at Rs 780.97 crore Ruby Khatun Khatun11 Nov 2017 10:47 AM ISTNew Delhi: Drug firm Aurobindo Pharma reported a 28.96 percent rise in its consolidated net profit to Rs 780.97 crore for the September quarter of the...
